Lagente V, Moodley I, Perrin S, Mottin G, Junien J L
Laboratoire de Pharmacologie Expérimentale et Moléculaire, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes I, France.
Eur J Pharmacol. 1994 Apr 1;255(1-3):253-6. doi: 10.1016/0014-2999(94)90107-4.
The effects of selective phosphodiesterase isozyme inhibitors on eosinophil infiltration induced by antigen challenge or by exposure to an aerosol of platelet-activating factor (PAF) were investigated in the guinea-pig. Pretreatment 24 h and 3 h before antigen challenge or PAF exposure with theophylline (100 mg/kg), rolipram (5 mg/kg) and Ro 20-1724 (30 mg/kg) significantly reduced the increase in eosinophil numbers in bronchoalveolar lavage fluid. In contrast, milrinone, SK&F 94-120 and zaprinast were ineffective against antigen-induced eosinophil recruitment. Theophylline, rolipram and Ro 20-1724 also significantly reduced the release of eosinophil peroxidase into the bronchoalveolar lavage fluid. It is suggested that inhibitors of type IV phosphodiesterase have anti-inflammatory effects in the airways and may be useful in the treatment of asthma.
在豚鼠中研究了选择性磷酸二酯酶同工酶抑制剂对抗原激发或暴露于血小板活化因子(PAF)气雾剂诱导的嗜酸性粒细胞浸润的影响。在抗原激发或PAF暴露前24小时和3小时,用氨茶碱(100mg/kg)、咯利普兰(5mg/kg)和Ro 20-1724(30mg/kg)预处理可显著减少支气管肺泡灌洗液中嗜酸性粒细胞数量的增加。相比之下,米力农、SK&F 94-120和扎普司特对抗原诱导的嗜酸性粒细胞募集无效。氨茶碱、咯利普兰和Ro 20-1724也显著减少了嗜酸性粒细胞过氧化物酶释放到支气管肺泡灌洗液中。提示IV型磷酸二酯酶抑制剂在气道具有抗炎作用,可能对哮喘治疗有用。